- Home
- CLDX vs LBTYK Comparison
CLDX vs LBTYK Comparison
Compare CLDX & LBTYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | LBTYK |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 1995 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CLDX | LBTYK |
|---|---|---|
| Price | $28.36 | $9.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $63.07 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 11-17-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | $12,743,000.00 | ★ $11,541,500,000.00 |
| Revenue This Year | $19.74 | $37.91 |
| Revenue Next Year | $373.52 | $31.00 |
| P/E Ratio | ★ N/A | $7.59 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $22.10 | $7.32 |
| 52 Week High | $45.14 | $13.12 |
Technical Indicators
Market Signals| Indicator | CLDX | LBTYK |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 65.21 |
| Support Level | $28.34 | $9.30 |
| Resistance Level | $31.47 | $12.12 |
| Average True Range (ATR) | 1.35 | 0.39 |
| MACD | 0.35 | 0.20 |
| Stochastic Oscillator | 71.35 | 99.02 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.